These 2 growth stocks may be huge winners in the next decade and beyond

Growth stocks often carry explosive potential to boost an investor’s wealth. Zaven Boyrazian shares two he thinks could do just that over the next decade.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Illustration of flames over a black background

Image source: Getty Images

Growth stocks exist to provide investors with the opportunity to multiply their money by large amounts. Of course, as many have been recently reminded, these enterprises typically come with significantly more risk and volatility.

Other than a few exceptions, this class of equities remain largely unpopular due to the continued economic uncertainty. However, consequently, that means potentially explosive investments are currently trading at discounted prices versus their historical premium valuations.

With that in mind, here are two stocks from my portfolio I’ve been topping up throughout 2023, so far.

Investing in the future of surgery

While it still sounds like something out of a science fiction novel, robotic surgery is becoming increasingly common in medical institutions worldwide.

These procedures are still largely more expensive to perform versus traditional methods. But this price barrier has been falling rapidly over the last decade. And with the pinpoint precision provided, patients take on less risk with faster recovery times. That means better quality healthcare while simultaneously reducing costs for hospitals.

That’s why Intuitive Surgical (NASDAQ:ISRG) is one of the larger positions within my growth portfolio. The company is the global leader in this rising industry, with 8,042 of its da Vinci surgical systems installed worldwide.

With hundreds of new systems installed every quarter, Intuitive now controls an estimated 80% of the global robotic surgery market. In other words, it has a near monopoly in an industry which, according to Grand View Research, is on track to expand by 16.5% annually between now and 2030.

Of course, no investment is without its risks. The high barriers to entry mean competition is currently scarce. But that won’t last forever. And if management can’t convince health insurance companies to include robotic surgery procedures in customer policies, growth may struggle to keep up with expectations.

Nevertheless, given the group’s explosive track record, I think these risks are worth taking.

Powering the cloud

Data centres have been money-making machines for cloud providers worldwide. But cloud technology wouldn’t exist today if it wasn’t for firms like Arista Networks (NYSE:ANET). Most consumers probably haven’t heard of this enterprise. But chances are they’ve relied on a server using the group’s tech.

Arista makes high-speed ethernet switches. These are ultimately responsible for the flow of traffic moving through servers, creating the world’s increasingly critical bandwidth. And while this sector has been historically dominated by the likes of Cisco, Arista has been systematically stealing market share for decades. And this trend looks set to continue.

At the end of 2022, the company launched its first 800 gigabit switch. It has double the bandwidth capacity of the group’s earlier generation, with an estimated 20-40% saving in electricity consumption. Apart from saving data centres considerable running costs, such performance will be critical for low-latency services from IoT, 5G, and AI devices.

With a focus on hyperscaler data centres, Arista has achieved tremendous growth. But that has also led to some serious customer concentration risk, with Microsoft and Meta Platforms responsible for 42% of the revenue stream! If either of these firms decides to switch to a competitor, it could be disastrous.

Having said that, even Cisco is seemingly struggling to keep up with Arista’s impressive pace of technological innovation. Therefore, while certainly risky, it remains a growth stock worth buying, in my opinion.

Randi Zuckerberg, a former director of market development and spokeswoman for Facebook and sister to Meta Platforms CEO Mark Zuckerberg, is a member of The Motley Fool's board of directors. Zaven Boyrazian has positions in Arista Networks and Intuitive Surgical. The Motley Fool UK has recommended Arista Networks, Intuitive Surgical, Meta Platforms, and Microsoft. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Aviva logo on glass meeting room door
Investing Articles

After falling another 5%, are Aviva shares too cheap to ignore?

£10,000 invested in Aviva shares five years ago would have grown 50% by now. But what might the future hold,…

Read more »

Two female adult friends walking through the city streets at Christmas. They are talking and smiling as they do some Christmas shopping.
Investing Articles

Next impresses again, but could its shares be about to crash?

Next shares have leapt after the retailer raised its full-year profits guidance. But could the FTSE 100 retailer be running…

Read more »

Investing Articles

Time to buy, after Next shares are lifted by storming FY results?

Retail sector weakness is holding back Next shares, is it? Tell that to the fashion shoppers who've driven up full-year…

Read more »

Three signposts pointing in different directions, with 'Buy' 'Sell' and 'Hold' on
Growth Shares

Why the Barclays share price is currently its most undervalued in months

Jon Smith talks through why the Barclays share price has struggled in recent weeks, and flags up reasons why it…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

10.7% yield! Should investors snap up Taylor Wimpey shares before they go ex-dividend on 2 April?

Harvey Jones is stunned by the double-digit yield available from Taylor Wimpey shares. But the FTSE 250 stock comes with…

Read more »

White female supervisor working at an oil rig
Investing For Beginners

Are investors taking a massive gamble with the Shell share price?

Jon Smith mulls the current state of play in the oil market and explains why he thinks further gains for…

Read more »

Young brown woman delighted with what she sees on her screen
Investing Articles

Stock market correction 2026: a rare chance to scoop up cheap UK shares?

The UK stock market's officially in a correction after a sharp drop in UK share prices, but our writer sees…

Read more »

Investing Articles

How much do you need in an ISA to aim for a £750 monthly second income?

Harvey Jones crunches the numbers to show how investors could aim for a high-and-rising second income from dividend-paying FTSE 100…

Read more »